| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 66.8× | −1.7× | |
| Price / Book | 16.8× | 2.0× | |
| Price / Sales | 13.6× | 3.9× | |
| Price / Free cash flow | 79.5× | −1.6× | |
| EV / EBITDA | 43.3× | −1.2× | |
| Earnings yield | 1.5% | −14.6% | |
| Free cash flow yield | 1.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.15 | −0.71% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.65 | −0.75% | $611.26B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.86 | −0.55% | $501.61B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.70 | +0.32% | $361.46B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.61 | −0.92% | $356.78B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.38 | −0.16% | $278.19B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.15 | −0.16% | $256.13B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $675.61 | −2.09% | $249.8B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.08 | −1.02% | $231.43B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.43 | −1.13% | $191.49B | 22.8× | 37.5% | +32.0% |
